
Sign up to save your podcasts
Or
Dr. Iyad Alnahhas interviews Dr. Craig Horbinski about his and his team's recent manuscript entitled "The novel DNA cross-linking agent KL-50 is active against patient-derived models of new and recurrent post-temozolomide mismatch repair-deficient glioblastoma", published online in Neuro-Oncology in December 2024.
4.8
1212 ratings
Dr. Iyad Alnahhas interviews Dr. Craig Horbinski about his and his team's recent manuscript entitled "The novel DNA cross-linking agent KL-50 is active against patient-derived models of new and recurrent post-temozolomide mismatch repair-deficient glioblastoma", published online in Neuro-Oncology in December 2024.
7,886 Listeners
398 Listeners
32,252 Listeners
111,562 Listeners
56,166 Listeners
21 Listeners
26 Listeners
111 Listeners
12,854 Listeners
15,174 Listeners
10,455 Listeners
74 Listeners
23 Listeners
4 Listeners
39 Listeners